[Defense of the esophageal mucosa as a therapeutic target in gastroesophageal reflux disease].
Piazuelo
E
E
Instituto Aragonés de Ciencias de la Salud, Zaragoza, España. epiazor@unizar.es
Lanas
A
A
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004942:Esophagitis, Peptic / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D004943:Esophagogastric Junction / Q000473:pathology; D004945:Esophagoscopy; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000473:pathology
D000897:Anti-Ulcer Agents